<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="27218" end="27225" sStart="27198" offset="20" sid="r8.suggest.v.0931" wn="3" wnkey="suggest%2:32:02::" text="Our results suggest that NOM cannot modulate MRP gene expression either." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="22003" end="22009" sStart="null" offset="171" sid="r11.strong.j.0793" wn="1" wnkey="strong%3:00:00::" text="The reversal effect of NOM was similar to that of VRP, which is a classical reversal agent with a high reversal activity; NOM therefore also has a strong reversal activity." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="15547" end="15553" sStart="null" offset="89" sid="r9.normal.j.0942" wn="2" wnkey="normal%3:00:02::" text="In MCF7/ADR cells treated with NOM (5 ?M) for 10 days the cell growth rate was normal compared with control cells, as judged by staining with trypan blue." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="10656" end="10661" sStart="null" offset="41" sid="r9.level.n.0579" wn="1" wnkey="level%1:07:00::" text="The specific gene expression level was determined semiquantitatively by calculating the ratio of density metric value from specific genes expressed in relation to the internal standard (specific gene expression/?-actin expression)." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="19914" end="19918" sStart="null" offset="165" sid="r9.kill.v.0792" wn="9" wnkey="kill%2:35:02::" text="P-gp is able to pump various anticancer drugs out of cells, thus resulting in a low intracellular drug concentration that is insufficient to kill tumour cells [ 18]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="20667" end="20671" sStart="null" offset="8" sid="r10.high.j.0928" wn="1" wnkey="high%3:00:02::" text="Because high doses of MG induce vomiting, oedema, dizziness and androgen-like side-effects, the ideal effective concentration is difficult to obtain in vivo . Therefore, the search for new drugs with low toxicity is in progress to meet an urgent need for clinical applications." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="2326" end="2334" sStart="null" offset="116" sid="r11.function.n.0469" wn="2" wnkey="function%1:07:00::" text="The reversal mechanism consists of, for example, binding directly to P-gp, inhibiting the transport function of drug efflux, increasing the intracellular accumulation of the drug and changing lipid mobility in the plasma membrane [ 4, 10, 11, 12]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21234" end="21238" sStart="null" offset="4" sid="r9.full.j.0928" wn="2147483647" wnkey="null" text="Its full chemical name is 3,20-diketo-6-methyl-17-?-hydroxy-19-norpregna-4,6-diene [ 9]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="15815" end="15819" sStart="null" offset="172" sid="r9.fold.v.0209" wn="2147483645" wnkey="null" text="The results showed that 20, 10 and 5 ?M NOM significantly increased the sensitivity of MCF7/ADR cells to ADR, the degrees of reversal being 21-fold, 12-fold and 8-fold, respectively (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21615" end="21619" sStart="null" offset="60" sid="r9.fold.v.0090" wn="2147483646" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21624" end="21628" sStart="null" offset="69" sid="r9.fold.v.0779" wn="2147483645" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18886" end="18890" sStart="null" offset="125" sid="r9.fold.v.0167" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21615" end="21619" sStart="null" offset="60" sid="r9.fold.v.0090" wn="2147483646" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="20440" end="20444" sStart="null" offset="121" sid="r9.fold.v.0892" wn="2147483645" wnkey="null" text="MG is a strong reversal agent: its capacity to increase intracellular accumulation of vincristine is 2-3-fold that of progesterone [ 6]." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18919" end="18923" sStart="null" offset="158" sid="r9.fold.v.0428" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="r9.fold.v.0408" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21615" end="21619" sStart="null" offset="60" sid="r9.fold.v.0090" wn="2147483645" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="18896" end="18900" sStart="null" offset="135" sid="null" wn="2147483645" wnkey="null" text="Marked increases in intracellular ADR accumulation were found in MCF7/ADR cells, the increases being 2.7-fold, 2.3-fold and 1.5-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21635" end="21639" sStart="null" offset="80" sid="r9.fold.v.0582" wn="" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="15806" end="15810" sStart="null" offset="163" sid="r9.fold.v.0178" wn="" wnkey="null" text="The results showed that 20, 10 and 5 ?M NOM significantly increased the sensitivity of MCF7/ADR cells to ADR, the degrees of reversal being 21-fold, 12-fold and 8-fold, respectively (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="21615" end="21619" sStart="null" offset="60" sid="r9.fold.v.0090" wn="" wnkey="null" text="The reversal effects of 20, 10 and 5 ?M NOM were 21-fold, 12-fold and 8-fold, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/bcr303.anc" start="19441" end="19452" sStart="null" offset="40" sid="r11.combination.n.0323" wn="1" wnkey="combination%1:14:00::" text="However, when ADR was used in combination with 20 ?M NOM, a marked arrest was seen." />
  </sentences>
</list>